Candidiasis, Oral clinical trials
The registry lists 48 studies for Candidiasis, Oral across more than 10 countries. 6 are recruiting or about to start. 33 of them are mainly about Candidiasis, Oral (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-23.
Get an email when these change. Save the Candidiasis, Oral studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Bristol-Myers Squibb (3) · Pfizer (3) · Raphael Freitas de Souza (2) · Janssen, LP (2) · Université de Montréal (2) · Schering-Plough (2) · Astellas Pharma Inc (2)
What is being tested here
Drugs under test in Candidiasis, Oral studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Fluconazole | 0 | 1 | 7 |
| Nystatin | 0 | 2 | 5 |
| Amphotericin B | 0 | 0 | 2 |
| Micafungin | 0 | 2 | 2 |
| Itraconazole | 0 | 0 | 2 |
| Ibrexafungerp | 0 | 0 | 1 |
| Nitric Oxide | 0 | 0 | 1 |
| Chitosan | 0 | 0 | 1 |
| Lacteol | 0 | 0 | 1 |
| Gentian Violet | 0 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Nov 2027Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model · University of Fujairah
Who these studies take
Of the 3 Candidiasis, Oral studies recruiting now, 2 (67%) set no upper age limit and 1 (33%) stop at 75 or younger. 2 (67%) take children under 18. 1 (33%) are for women only and 0 (0%) for men only; 2 (67%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (33%) | 0 (0%) |
| 18 | 2 (67%) | 1 (33%) |
| 30 | 2 (67%) | 1 (33%) |
| 40 | 2 (67%) | 1 (33%) |
| 50 | 2 (67%) | 1 (33%) |
| 65 | 2 (67%) | 1 (33%) |
| 75 | 2 (67%) | 1 (33%) |
| 85 | 2 (67%) | 1 (33%) |
Across all 48 studies, recruiting or not: 33% stop at 75 or younger and 25% at 65; 44% take children; 4% are for women only and 0% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 48 of 48. search them.
- Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant OutcomesRecruitingNCT059086821 country
- Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led ModelNot yet recruitingNCT07721090Not applicable
- Oropharyngeal Candidiasis (OPC) and S-ECCRecruitingNCT057611971 country
- Efficacy of the Vacucis Candida® AutovaccineNot yet recruitingNCT05289375Not applicable1 country
- CelAgace™ OraRinse Solution for Treatment of CandidiasisNot yet recruitingNCT03250923Phase 1/21 country
- Use of Maqui Berry Extract in Treating Oral Candidiasis in Diabetes Mellitus Patients and Systemically Healthy PersonsRecruitingNCT05916729Phase 41 country
- Efficacy of 1% Nanochitosan Solution in the Treatment of Denture StomatitisCompletedNCT07694024Phase 21 country
- Pharmacokinetic Study in Healthy Lactating Women Exposed to IbrexafungerpCompletedNCT06954493Phase 11 country
- Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal CandidiasisCompletedNCT06120816Phase 11 country
- Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BIDCompletedNCT00235053Phase 41 country
- The Anti-fungal Effect of Miconazol Versus Miconazol-Loaded Chitosan NanoparticlesCompletedNCT06072716Phase 11 country
- Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).CompletedNCT050946871 country
- A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With FluconazoleCompletedNCT00001065Phase 23 countries
- A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent ThrushCompletedNCT00000951Phase 42 countries
- Effect of Oral Hygienization in Newborn on Candida Spp ColonizationStatus unknownNCT04410250Not applicable1 country
- Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida SpeciesCompletedNCT03894839Not applicable1 country
- Relationship Between Oral Hygiene in Newborns and Candida Spp.Status unknownNCT03873753Not applicable1 country
- The Effectiveness of Palatal Brushing on Denture StomatitisCompletedNCT02686632Not applicable1 country
- Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal AntisepticCompletedNCT02818803Phase 31 country
- Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of TrochesCompletedNCT00835029Phase 21 country
- Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal CandidiasisCompletedNCT00666185Phase 33 countries
- Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCompletedNCT00665639Phase 34 countries
- Efficacy of a Propolis-based Denture CleanserCompletedNCT01237782Not applicable1 country
- Experimental Denture PastesCompletedNCT01237795Not applicable1 country
- Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal CandidiasisCompletedNCT02184351Phase 3
- The Effect of Palatal Brushing on Denture StomatitisCompletedNCT01643876Phase 12 countries
- Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation TherapyCompletedNCT00768794Not applicable1 country
- Novel Rinse to Treat in Oral Candidiasis in Cancer PatientsCompletedNCT006129631 country
- Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral CandidiasisCompletedNCT00659971Phase 21 country
- The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV InfectionCompletedNCT000014481 country
- Fluconazole Prophylaxis of Thrush in AIDSCompletedNCT00001542Phase 41 country
- A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2CompletedNCT00001812Phase 31 country
- A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal CandidiasisCompletedNCT00128323Phase 31 country
- Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARCCompletedNCT00002057Not applicable1 country
- A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related SyndromesCompletedNCT00002293Not applicable1 country
- Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised PatientsCompletedNCT00002041Not applicable1 country
- The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected PatientsCompletedNCT00002431Not applicable1 country
- A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDSCompletedNCT00002282Not applicable1 country
- Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole TreatmentCompletedNCT00002394Not applicable1 country
- A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune SystemsCompletedNCT00002304Not applicable2 countries
- Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency SyndromeCompletedNCT00002112Not applicable1 country
- Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk GroupsCompletedNCT00004781
- Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive PatientsCompletedNCT00002446Phase 32 countries
- Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)CompletedNCT00002043Not applicable1 country
- A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With FluconazoleCompletedNCT00002341Not applicable1 country
- A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive PatientsCompletedNCT00002399Phase 218 countries
- An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.CompletedNCT00002133Not applicable1 country
- Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With FluconazoleTerminatedNCT00005920Phase 21 country